These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15067624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N, Savarino V.
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [Abstract] [Full Text] [Related]

  • 3. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.
    Song CW, Chun HJ, Kim CD, Ryu HS, Choe JG, Hyun JH.
    Korean J Intern Med; 1998 Feb; 13(1):15-21. PubMed ID: 9538626
    [Abstract] [Full Text] [Related]

  • 4. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN, Archambault A.
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [Abstract] [Full Text] [Related]

  • 5. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia.
    Distrutti E, Fiorucci S, Hauer SK, Pensi MO, Vanasia M, Morelli A.
    Aliment Pharmacol Ther; 2002 Mar; 16(3):613-22. PubMed ID: 11876717
    [Abstract] [Full Text] [Related]

  • 6. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR, Biagi F, Albano O, Bianchi Porro G, Cheli R, Mazzacca G, Miglio F, Naccarato R, Quaglino D, Surrenti C, Verme G, Gasbarrini G.
    Ital J Gastroenterol; 1996 Mar; 28(6):317-23. PubMed ID: 8891846
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.
    Lozano R, Concha MP, Montealegre A, de Leon L, Villalba JO, Esteban HL, Cromeyer M, García JR, Brossa A, Lluberes G, Sandí EI, Quirós HB.
    Ther Clin Risk Manag; 2007 Mar; 3(1):149-55. PubMed ID: 18360622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T, Barnert J, Dumitrascu DL, Fischer J, Wienbeck M.
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
    al-Quorain A, Larbi EB, al-Shedoki F.
    Scand J Gastroenterol; 1995 Jun; 30(6):531-4. PubMed ID: 7569759
    [Abstract] [Full Text] [Related]

  • 11. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
    Mansi C, Savarino V, Vigneri S, Perilli D, Melga P, Sciabà L, De Martini D, Mela GS.
    Am J Gastroenterol; 1995 Nov; 90(11):1989-93. PubMed ID: 7485007
    [Abstract] [Full Text] [Related]

  • 12. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
    Chung JM.
    Scand J Gastroenterol Suppl; 1993 Nov; 195():11-4. PubMed ID: 8516653
    [Abstract] [Full Text] [Related]

  • 13. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A, Fidalgo P, Freire A, Matos L.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [Abstract] [Full Text] [Related]

  • 14. [Levosulpiride versus domperidone in the treatment of functional dyspepsia].
    Mangiameli A, Brogna A, Catanzaro R, Sofia M, Blasi A.
    Clin Ter; 1994 Feb; 144(2):107-14. PubMed ID: 7910127
    [Abstract] [Full Text] [Related]

  • 15. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
    Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H.
    Clin Ther; 1987 Feb; 10(1):44-51. PubMed ID: 3329964
    [Abstract] [Full Text] [Related]

  • 16. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
    Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M.
    Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
    [Abstract] [Full Text] [Related]

  • 17. Comparative Efficacy of Various Pharmacological Interventions in the Treatment of Functional Dyspepsia: A Network Meta-Analysis.
    Liang L, Yu J, Xiao L, Wang G.
    Dig Dis Sci; 2022 Jan; 67(1):187-207. PubMed ID: 33590403
    [Abstract] [Full Text] [Related]

  • 18. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A, Heydenreich CJ, Wieland V, Hufnagel R, Hotz J.
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [Abstract] [Full Text] [Related]

  • 19. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
    Halter F, Miazza B, Brignoli R.
    Scand J Gastroenterol; 1994 Jul; 29(7):618-23. PubMed ID: 7939398
    [Abstract] [Full Text] [Related]

  • 20. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W, Vinson B, Sassin I.
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.